[Federal Register: September 15, 2008 (Volume 73, Number 179)]
[Notices]
[Page 53280-53281]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr15se08-106]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application;
Correction
On August 6, 2008, the Drug Enforcement Administration (DEA)
published a Notice of Application for Registration for Chattem
Chemicals Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga,
Tennessee 37409 in the Federal Register pursuant to 21 CFR 1301.33(a)
(73 FR 45784). On May 28,
[[Page 53281]]
2008, Chattem Chemicals Inc., had made application by renewal to DEA as
a bulk manufacturer of the certain basic classes of controlled
substances listed in schedules I and II. The Notice of Application
published August 6, 2008, listed the following basic classes of
controlled substances for which Chattem Chemicals Inc. sought
registration as a bulk manufacturer:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
4-Methoxyamphetamine (7411)............... I
Difenoxin (9168).......................... I
Amphetamine (1100)........................ II
Methamphetamine (1105).................... II
Methylphenidate (1724).................... II
Pentobarbital (2270)...................... II
Codeine (9050)............................ II
Oxycodone (9143).......................... II
Hydrocodone (9193)........................ II
Meperidine (9230)......................... II
Dextropropoxyphene, bulk (non-dosage II
forms) (9273).
Morphine (9300)........................... II
Thebaine (9333)........................... II
Noroxymorphone (9668)..................... II
Alfentanil (9737)......................... II
Sufentanil (9740)......................... II
Fentanyl (9801)........................... II
------------------------------------------------------------------------
DEA inadvertently did not include the following substances for
which Chattem Chemicals Inc. also seeks registration as a bulk
manufacturer:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Lisdexamfetamine Mesylate (1205).......... II
Dihydrocodeine (9120)..................... II
Dihydromorphine (9145).................... II
Hydromorphone (9150)...................... II
Oripavine (9330).......................... II
Oxymorphone (9652)........................ II
Reminfentanil (9739)...................... II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for distribution to its customers.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substances, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Federal Register
Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia
22152.
As DEA inadvertently did not include all basic classes of
controlled substances for which Chattem Chemicals Inc. sought
registration in the Notice of Application published August 6, 2008, DEA
is extending the comment period for this application in accordance with
21 CFR 1301.33(a). Therefore, the comment period for this application
is extended from October 6, 2008 to November 14, 2008.
Dated: September 8, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E8-21461 Filed 9-12-08; 8:45 am]
BILLING CODE 4410-09-P